Lung Cancer Video Library - Evolving Options in First Line Treatment of ALK-Positive Non-Small Cell Lung Cancer (NSCLC)


Dr. Luis Raez, MD FACP FCCP, Chief of Hem/Onc and Med. Dir. at Memorial Cancer Institute, and Clinical Associate Prof. of Medicine at FL International University discusses evolving options in first line treatment of ALK-Positive non-small cell lung cancer (NSCLC).

Subscribe to luis raez